Literature DB >> 9930105

MRI evaluation of steroid- or alcohol-related osteonecrosis of the femoral condyle.

T Sakai1, N Sugano, K Ohzono, M Matsui, K Hiroshima, T Ochi.   

Abstract

We reviewed 30 patients (46 knees) with steroid- or alcohol-related osteonecrosis of the femoral condyle. Their average age was 35 (14-61) years and the mean observation time was 7 (3-16) years. The medio-lateral extent and the anterior-posterior (AP) location of the necrotic lesion were evaluated on T1-weighted MRI and related to the collapse of the condyle. The size of the lesion was classified into three categories on the mid-coronal MRI of the femoral condyle: there were 44 small, 20 medium, and 9 large lesions. The condyle was divided into 3 zones: anterior, middle, and posterior. The location of the lesion was evaluated on the mid-sagittal image. There were 7 anterior, 9 middle, 29 posterior, 14 middle and posterior and, in 14 cases, all 3 zones were involved. 44 small lesions did not collapse, while 6/20 medium lesions and 5/9 large lesions collapsed. No lesion involving only one zone collapsed, while 4/14 lesions involving the middle and posterior zones and 7/14 lesions involving all three zones progressed to collapse. 4/6 condyles with large necrotic lesions involving all three zones collapsed. We conclude that the extent of the necrotic lesion on both the mid-coronal and mid-sagittal planes is of importance for the prognosis of osteonecrosis of the femoral condyle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9930105     DOI: 10.3109/17453679808999263

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  10 in total

Review 1.  Osteonecrosis in children after therapy for malignancy.

Authors:  Sue C Kaste; Evguenia J Karimova; Michael D Neel
Journal:  AJR Am J Roentgenol       Date:  2011-05       Impact factor: 3.959

Review 2.  MR imaging of osteonecrosis of the knee in children with acute lymphocytic leukemia.

Authors:  E Jane Karimova; Sue C Kaste
Journal:  Pediatr Radiol       Date:  2007-09-01

3.  How does osteonecrosis about the knee progress in young patients with leukemia?: a 2- to 7-year study.

Authors:  E J Karimova; A Wozniak; J Wu; M D Neel; S C Kaste
Journal:  Clin Orthop Relat Res       Date:  2010-06-26       Impact factor: 4.176

4.  Bone scintigraphy for osteonecrosis of the knee in patients with non-traumatic osteonecrosis of the femoral head: comparison with magnetic resonance imaging.

Authors:  T Sakai; N Sugano; T Nishii; K Haraguchi; H Yoshikawa; K Ohzono
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

5.  Extent of osteonecrosis on MRI predicts humeral head collapse.

Authors:  Takashi Sakai; Nobuhiko Sugano; Takashi Nishii; Takehito Hananouchi; Hideki Yoshikawa
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

6.  Osteonecrosis in kidney recipients: has hypocalcaemia a role?

Authors:  Alia Mohamed Atallah; Mohamed E Abou El-Ghar; Mohamed A Ghoneim
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

7.  The relationship between apolipoprotein genes polymorphisms and susceptibility to osteonecrosis of the femoral head: a meta-analysis.

Authors:  Yangquan Hao; Hao Guo; Zhaochen Xu; Handeng Qi; Yugui Wang; Chao Lu; Jie Liu; Puwei Yuan
Journal:  Lipids Health Dis       Date:  2018-08-17       Impact factor: 3.876

Review 8.  Subchondral insufficiency fracture of the knee: review of current concepts and radiological differential diagnoses.

Authors:  Junko Ochi; Taiki Nozaki; Akimoto Nimura; Takehiko Yamaguchi; Nobuto Kitamura
Journal:  Jpn J Radiol       Date:  2021-11-29       Impact factor: 2.701

9.  Glucocorticoid-induced avascular bone necrosis: diagnosis and management.

Authors:  K L Chan; C C Mok
Journal:  Open Orthop J       Date:  2012-10-05

10.  Osteonecrosis of the Knee After Anterior Cruciate Ligament Reconstruction: A Report of 5 Cases.

Authors:  Drew A Lansdown; Jeremy Shaw; Christina R Allen; C Benjamin Ma
Journal:  Orthop J Sports Med       Date:  2015-03-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.